在患有牛皮和牛皮性关节炎的患者的抗TNF治疗期间,免疫细胞的活性
Aleksandra Petrovic1, Victoria Marie Samuelsen1, Richard Davies1
1Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
Clinical and experimental immunology
|August 9, 2024
概括
长期治疗牛皮和牛皮性关节炎的Infliximab会影响免疫细胞的组成. 自然杀手细胞减少,而单细胞和B细胞子集显示出改变的活动,表明正在进行的炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
背景情况:
- 牛皮和牛皮性关节炎涉及免疫失调和全身炎症.
- 瘤坏死因子抑制剂,如因弗利西马布,是有效的治疗方法.
研究的目的:
- 研究因弗利西马布对患有牛皮和牛皮性关节炎的患者循环免疫细胞群的长期影响.
- 评估与疾病严重程度和治疗有关的免疫细胞活性和组成.
主要方法:
- 多色流细胞计用于分析周边血液单核细胞.
- 免疫细胞子集 (NK细胞,单细胞,B细胞) 和激活标志物被量化.
- 24名因弗力西马布治疗患者和32名健康对照组之间的比较.
主要成果:
- 在牛皮关节炎患者中观察到自然杀手 (NK) 细胞和CD56dimCD16+NK细胞的频率降低.
- 在牛皮/牛皮性关节炎中观察到变化的单细胞群 (CD14+CD16+,CD14+CD16-) 和增加的单细胞活性 (CD38+).
- 在牛皮患者中检测到B细胞子集的变化,包括过渡性B细胞的减少.
结论:
- 长期治疗infliximab可能无法完全解决潜在的免疫失调和全身炎症.
- 尽管临床稳定,持续的免疫细胞变化表明正在治疗的患者正在进行的病理生理过程.
相关概念视频
T Cell Types and Functions
966
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
966
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
109
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
109


